TY - JOUR T1 - Decreasing median age of COVID-19 cases in the United States – changing epidemiology or changing surveillance? JF - medRxiv DO - 10.1101/2020.07.22.20160119 SP - 2020.07.22.20160119 AU - Dina N. Greene AU - Michael L. Jackson AU - David R. Hillyard AU - Julio C. Delgado AU - Robert Schmidt Y1 - 2020/01/01 UR - http://medrxiv.org/content/early/2020/07/24/2020.07.22.20160119.abstract N2 - Background Understanding and monitoring the demographics of SARS-CoV-2 infection can inform strategies for prevention. Surveillance monitoring has suggested that the age distribution of people infected with SARS-CoV-2 has changed since the pandemic began, but no formal analysis has been performed.Methods Retrospective review of SARS-CoV-2 molecular testing results from a national reference laboratory was performed. Result distributions by age and positivity were compared between early period (March-April 2020) and late periods (June-July 2020) of the COVID-19 pandemic. Additionally, a sub-analysis compared changing age distributions between inpatients and outpatients.Results There were 277,601 test results of which 19320 (7.0%) were positive. The median age of infected people declined over time (p < 0.0005). In March-April, the median age of positive people was 40.8 years (Interquartile range (IQR): 29.0 – 54.1). In June-July, the median age of positive people was 35.8 years (IQR: 24.0 – 50.2). The positivity rate of patients under 50 increased from 6.0 to 10.6 percent and the positivity rate for those over 50 decreased from 6.3 to 5.0 percent between the early and late periods. The trend was only observed for outpatient populations.Conclusions We confirm that there is a trend toward decreasing age among persons with laboratory- confirmed SARS-CoV-2 infection, but that these trends seem to be specific to the outpatient population. Overall, this suggests that observed age-related trends are driven by changes in testing patterns rather than true changes in the epidemiology of SARS-CoV-2 infection. This calls for caution in interpretation of routine surveillance data until testing patterns stabilize.Summary We used national reference laboratory data to compare ages of patients tested for SARS-CoV-2 in March/April 2020 vs. June/July. Median age declined overall, but increased for inpatients, suggesting that declining age is due to changes in surveillance, not COVID-19 epidemiology.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNo external funding was received.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The study was covered under exemption umbrella deidentified data (Utah IRB 00082990).All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesOur data set is limited (contains some PHI) and cannot be shared. ER -